Elevated levels of plasma Big endothelin-1 and its relation to hypertension and skin lesions in individuals exposed to arsenic

Toxicology and Applied Pharmacology

Volumn 259, Issue 2, 2012, Pages 187-194

  Hossain, Ekhtear ^a   Islam, Khairul ^a   Yeasmin, Fouzia ^a   Karim, Md Rezaul ^b   Rahman, Mashiur ^a   Agarwal, Smita ^a   Hossain, Shakhawoat ^a   Aziz, Abdul ^a   Al Mamun, Abdullah ^a   Sheikh, Afzal ^a   Haque, Abedul ^a   Hossain, M Tofazzal ^a   Hossain, Mostaque ^c   Haris, Parvez I ^d   Ikemura, Noriaki ^e   Inoue, Kiyoshi ^e   Miyataka, Hideki ^e   Himeno, Seiichiro ^e   Hossain, Khaled ^a  

^a UNIVERSITY OF RAJSHAHI   (Bangladesh)

^b ISLAMIC UNIVERSITY   (Bangladesh)

^c Bangladesh Institute of Research and Rehabilitation in Diabetes Endocrine and Metabolic Disorders   (Bangladesh)

^d DE MONTFORT UNIVERSITY   (United Kingdom)

^e TOKUSHIMA BUNRI UNIVERSITY   (Japan)

Author keywords

Arsenic; Bangladesh; Big endothelin; Hypertension; Skin lesions

Indexed keywords

ARSENIC; BIG ENDOTHELIN 1; DRINKING WATER;

ADULT; ARTICLE; BANGLADESH; CONTROLLED STUDY; DOSE RESPONSE; ENDEMIC DISEASE; ENZYME IMMUNOASSAY; FEMALE; HAIR LEVEL; HUMAN; HYPERTENSION; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; NAIL; PROTEIN BLOOD LEVEL; SKIN DEFECT; WATER CONTAMINATION;

ADOLESCENT; ADULT; ARSENIC; ARSENIC POISONING; BANGLADESH; ENDOTHELIN-1; FEMALE; HAIR; HUMANS; HYPERTENSION; LINEAR MODELS; MALE; MIDDLE AGED; NAILS; SKIN DISEASES; WATER SUPPLY; YOUNG ADULT;

EID: 84857231803     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2011.12.023     Document Type: Article

References (60)

1. Agahian B., Lee J.S., Nelson J.H., Johns R.E. Arsenic levels in fingernails as a biological indicator of exposure to arsenic. Am. Ind. Hyg. Assoc. J. 1990, 51:646-651.
2. Ahsan H., Perrin M., Rahman A., Parvez F., Stute M., Zheng Y., Milton A.H., Brandt-Rauf P., van Geen A., Graziano J. Associations between drinking water and urinary arsenic levels and skin lesions in Bangladesh. J. Occup. Environ. Med. 2000, 42:1195-1201.
3. Ali N., Hoque M.A., Haque A., Salam K.A., Karim M.R., Rahman A., Islam K., Saud Z.A., Khalek M.A., Akhand A.A., Hossain M., Mandal A., Karim M.R., Miyataka H., Himeno S., Hossain K. Association between arsenic exposure and plasma cholinesterase activity: a population based study in Bangladesh. Environ. Health 2010, 9:36.
4. Best P.J., McKenna C.J., Hasdai D., Holmes D.R., Lerman A. Chronic endothelin receptor antagonism preserves coronary endothelial function in experimental hypercholesterolemia. Circulation 1999, 99:1747-1752.
5. BGS, DPHE British Geological Survey (BGS) and Department of Public Health Engineering (DPHE), 2001. BGS Technical Report WC/00/19 2001, Volume 1. Keyworth, Available:, [accessed on 20/12/2011]. http://www.bgs.ac.uk/arsenic/bphase2/Reports/Vol1Summary.pdf, D.G. Kinniburgh, P.L. Smedley (Eds.).
6. Bilszta J.L., Dusting G.J., Jiang F. Arsenite increases vasoconstrictor reactivity in rat blood vessels: role of endothelial nitric oxide function. Int. J. Toxicol. 2006, 25:303-310.
7. Caldwell B.K., Caldwell J.C., Mitra S.N., Smith W. Tube wells and arsenic in Bangladesh: challenging a public health success story. Int. J. Popul. Geogr. 2003, 9:23-38.
8. Chen C.J., Hsueh Y.M., Lai M.S., Shyu M.P., Chen S.Y., Wu M.M., Kuo T.L., Tai T.Y. Increased prevalence of hypertension and long-term arsenic exposure. Hypertension 1995, 25:53-60.
9. Chen K.L., Amarasiriwardena C.J., Christiani D.C. Determination of total arsenic concentrations in nails by inductively coupled plasma mass spectrometry. Biol. Trace Elem. Res. 1999, 67:109-125.
10. Chen Y., Santella R.M., Kibriya M.G., Wang Q., Kappil M., Verret W.J., Graziano J.H., Ahsan H. Association between arsenic exposure from drinking water and plasma levels of soluble cell adhesion molecules. Environ. Health Perspect. 2007, 115:1415-1420.
11. Chowdhury A.M.R. Arsenic crisis in Bangladesh. Sci. Am. 2004, 291:86-91.
12. Cody R.J., Haas G.J., Binkley P.F., Capers Q., Kelley R. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation 1992, 85:504-509.
13. de Nucci G., Thomas R., D'Orleans-Juste P., Antunes E., Walder C., Warner T.D., Vane J.R. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:9797-9800.
14. Ergul A. Endothelin-1 and diabetic complications: focus on the vasculature. Pharmacol. Res 2011, [Online 1 February 2011]. 10.1016/j.phrs.2011.01.012.
15. Gault A.G., Rowland H.A., Charnock J.M., Wogelius R.A., Gomez-Morilla I., Vong S., Leng M., Samreth S., Sampson M.L., Polya D.A. Arsenic in hair and nails of individuals exposed to arsenic-rich ground waters in Kandal province, Cambodia. Sci. Total. Environ. 2008, 393:168-176.
16. Guha Mazumder D.N., Haque R., Ghosh N., De B.K., Santra A., Chakraborty D., Smith A.H. Arsenic levels in drinking water and the prevalence of skin lesions in West Bengal, India. Int. J. Epidemiol. 1998, 27:871-877.
17. Hachiya A., Kobayashi A., Yoshida Y., Kitahara T., Takema Y., Imokawa G. Biphasic expression of two paracrine melanogenic cytokines, stem cell factor and endothelin-1, in ultraviolet B-induced human melanogenesis. Am. J. Pathol. 2004, 165:2099-2109.
18. Harvey C.F., Swartz C.H., Badruzzaman A.B.M., Keon-Blute N., Yu W., Ali M.A., Jay J., Beckie R., Niedan V., Brabander D., Oates P.M., Ashfaque K.N., Islam S., Hemond H.F., Ahmad M.F. Arsenic mobility and groundwater extraction in Bangladesh. Science 2002, 298:1602-1606.
19. Hemsen A., Ahlborg G., Ottosson-Seeberger A., Lundberg J.M. Metabolism of Big endothelin-1 (1-38) and (22-38) in human circulation in relation to production of endothelin-1 (1-21). Regul. Pept. 1995, 55:287-297.
20. Hossain M.A., Akai J., Mihaljevič M., Arif M.S., Ahmed G., Shafi M.T., Rahman M.M. Arsenic contamination in groundwater of Bangladesh: perspectives on geochemical, microbial and anthropogenic issues. Water 2011, 3:1050-1076.
21. Ishibashi M., Ito N., Fujita M., Furue H., Yamaji T. Endothelin-1 as an aggravating factor of disseminated intravascular coagulation associated with malignant neoplasms. Cancer 1994, 73:191-195.
22. Islam F.S., Gault A.G., Boothman C., Polya D.A., Charnock J.M., Chatterjee D., Lloyd J.R. Role of metal-reducing bacteria in arsenic release from Bengal delta sediments. Nature 2004, 430:68-71.
23. Jiao W., Xu J., Zheng J., Shen Y., Lin L., Li J. Elevation of circulating big endothelin-1: an independent prognostic factor for tumor recurrence and survival in patients with esophageal squamous cell carcinoma. BMC Cancer 2008, 8:334. [Online 15 November 2008]. 10.1186/1471-2407-8-334.
24. Jordan W., Reinbacher A., Cohrs S., Grunewald R.W., Mayer G., Rüther E., Rodenbeck A. Obstructive sleep apnea: plasma endothelin-1 precursor but not endothelin-1 levels are elevated and decline with nasal continuous positive airway pressure. Peptides 2005, 26:1654-1660.
25. Karim M.R., Salam K.A., Hossain E., Islam K., Ali N., Haque A., Saud Z.A., Yeasmin T., Hossain M., Miyataka H., Himeno S., Hossain K. Interaction between chronic arsenic exposure via drinking water and plasma lactate dehydrogenase activity. Sci. Total. Environ. 2010, 409:278-283.
26. Kligerman A.D., Doerr C.L., Tennant A.H., Harrington-Brock K., Allen J.W., Winkfield E., Poorman-Allen P., Kundu B., Funasaka K., Roop B.C., Mass M.J., DeMarini D.M. Methylated trivalent arsenicals as candidate ultimate genotoxic forms of arsenic: induction of chromosomal mutations but not gene mutations. Environ. Mol. Mutagen. 2003, 42:192-205.
27. Kwok R.K., Mendola P., Liu Z.Y., Savitz D.A., Heiss G., Ling H.L., Xia Y., Lobdell D., Zeng D., Thorp J.M., Creason J.P., Mumford J.L. Drinking water arsenic exposure and blood pressure in healthy women of reproductive age in Inner Mongolia, China. Toxicol. Appl. Pharmacol. 2007, 222:337-343.
28. Lan C.C., Wu C.S., Cheng C.M., Yu C.L., Chen G.S., Yu H.S. Pigmentation in basal cell carcinoma involves enhanced endothelin-1 expression. Exp. Dermatol. 2005, 14:528-534.
29. Lee M.Y., Jung B.I., Chung S.M., Bae O.N., Lee J.Y., Park J.D., Yang J.S., Lee H., Chung J.H. Arsenic-induced dysfunction in relaxation of blood vessels. Environ. Health Perspect. 2003, 111:513-517.
30. Lerman A., Holmes D.R., Bell M.R., Garratt K.N., Nishimura R.A., Burnett J.C. Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation 1995, 92:2426-2431.
31. Leveson S.H., Wiggins P.A., Giles G.R., Parkin A., Robinson P.J. Deranged liver blood flow patterns in the detection of liver metastases. Br. J. Surg. 1985, 72:128-130.
32. Levin E.R. Endothelins. N. Engl. J. Med. 1995, 333:356-363.
33. MacCumber M.W., Ross A.C., Snyder S.H. Endothelin in the brain: receptors, mitogenesis, and biosynthesis in glial cells. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:2359-2363.
34. Mäki-Paakkanen J., Kurttio P., Paldy A., Pekkanen J. Association between the clastogenic effect in peripheral lymphocytes and human exposure to arsenic through drinking water. Environ. Mol. Mutagen. 1998, 32:301-313.
35. Michael J.R., Markewitz B.A., Kohan D.E. Oxidant stress regulates basal endothelin-1 production by cultured rat pulmonary endothelial cells. Am. J. Physiol. 1997, 273:768-774.
36. Murase D., Hachiya A., Amano Y., Ohuchi A., Kitahara T., Takema Y. The essential role of p53 in hyperpigmentation of the skin via regulation of paracrine melanogenic cytokine receptor signaling. J. Biol. Chem. 2009, 284:4343-4353.
37. Nelson J.B., Opgenorth T.J., Fisher L.A., Frank S.M. Perioperative plasma endothelin-1 and Big endothelin-1 concentration in elderly patients undergoing major surgical procedures. Anaesth. Analg. 1998, 88:898-903.
38. Pacher R., Bergler-Klein J., Globits S., Teufelsbauer H., Schuller M., Krauter A., Ogris E., Rödler S., Wutte M., Hartter E. Plasma big endothelin-1 concentrations in congestive heart failure patients with or without systemic hypertension. Am. J. Cardiol. 1993, 71:1293-1299.
39. Plumpton C., Haynes W.G., Webb D.J., Davenport A.P. Phosphoramide inhibition of the in vivo conversion of big endothelin-1 to endothelin-1 in human forearm. Br. J. Pharmacol. 1995, 116:1821-1828.
40. Plumpton C., Ferro C.J., Haynes W.G., Webb D.J., Davenport A.P. The increase in human plasma immunoreactive endothelin but not big endothelin-1 or its C-terminal fragment induced by systemic administration of the endothelin antagonist TAK-044. Br. J. Pharmacol. 1996, 119:311-314.
41. Polizzotto M.L., Harvey C.F., Li G., Badruzzman B., Ali A., Newville M., Sutton S., Fendorf S. Solid-phases and desorption processes of arsenic within Bangladesh sediments. Chem. Geol. 2006, 228:97-111.
42. Rahman M., Tondel M., Ahmad S.A., Chowdhury I.A., Faruquee M.H., Axelson O. Hypertension and arsenic exposure in Bangladesh. Hypertension 1999, 33:74-78.
43. Rivera M., Cortes R., Portoles M., Valero R., Sancho-Tello J.M., Martinez-Dolz L., Sevilla B., Taléns-Visconti R., Jordán A., Miró V., Pérez-Boscá J.L., Marín F., Climent V., García de Burgos F., Payá R., Sogorb F., Bertomeu V., Salvador A. Plasma concentration of big endothelin-1 and its relation with plasma NT-proBNP and ventricular function in heart failure patients. Rev. Esp. Cardiol. 2005, 58:278-284.
44. Rubanyi G.M., Polokoff M.A. Endothelins: molecular biology, biochemistry, pharmacology, physiology and pathophysiology. Pharmacol. Rev. 1994, 46:325-415.
45. Sacar T., Gunduz K., Var A., Uyanik B.S. Serum lipid fractions, nitric oxide and plasma endothelin-1 levels in actinic keratosis. Clin. Exp. Dermatol. 2005, 30:96-97.
46. Schiffrin E.L., Deng L.Y., Larochelle P. Blunted effects of endothelin upon small subcutaneous resistance arteries of mild essential hypertensive patients. J. Hypertens. 1992, 10:437-444.
47. Schmitt M.T., Schreinemachers D., Wu K., Ning Z., Zhao B., Le X.C., Mumford J.L. Human nails as a biomarker of arsenic exposure from well water in Inner Mongolia: comparing atomic fluorescence spectrometry and neutron activation analysis. Biomarkers 2005, 10:95-104.
48. Simpson R.A., Dickinson T., Porter K.E., London N.J., Hemingway D.M. Raised levels of plasma Big ET-1 in patients with colorectal cancer. Br. J. Surg. 2000, 87:1409-1413.
49. Soucy N.V., Mayka D., Klei L.R., Nemec A.A., Bauer J.A., Barchowsky A. Neovascularization and angiogenic gene expression following chronic arsenic exposure in mice. Cardiovasc. Toxicol. 2005, 5:29-41.
50. Sutton N.B., van der Kraan G.M., van Loosdrecht M.C.M., Bruining G.M.J., Schotting R.J. Characterization of geochemical constituents and bacterial populations associated with As mobilization in deep and shallow tube wells in Bangladesh. Water Res. 2009, 43:1720-1730.
51. Teng X.J., Shen Z.X., Xiang J.J., Shen L., Yuan L., Guo J., Wang X.L. Pre- and post-operative plasma big endothelin-1 levels in patients with gastric carcinoma undergoing radical gastrectomy. Anticancer Res. 2006, 26:2503-2508.
52. Van Geen A., Zheng Y., Goodbred S., Horneman A., Aziz Z., Cheng Z., Stute M., Mailloux B., Weinman B., Hoque M.A., Seddique A.A., Hossain M.S., Chowdhury S.H., Ahmed K.M. Flushing history as a hydrogeological control on the regional distribution of arsenic in shallow groundwater of the Bengal Basin. Environ. Sci. Technol. 2008, 42:2283-2288.
53. Vural P., Erzengin D., Canbaz M., Selçuki D. Nitric oxide and endothelin-1,2 in actinic keratosis and basal cell carcinoma: changes in nitric oxide/endothelin ratio. Int. J. Dermatol. 2001, 40:704-708.
54. Wagner O.F., Christ G., Wojta J., Vierhapper H., Parzer S., Nowotny P.J., Schneider B., Waldhäusl W., Binder B.R. Polar secretion of endothelin-1 by cultured endothelial cells. J. Biol. Chem. 1992, 267:16066-16068.
55. Wei C.M., Lerman A., Rodeheffer R.J., McGregor C.G., Brandt R.R., Wright S., Heublein D.M., Kao P.C., Edwards W.D., Burnett J.C. Endothelin in human congestive heart failure. Circulation 1994, 89:1580-1586.
56. WHO Arsenic and arsenic compounds. Environmental Health Criteria 2001, 224. World Health Organization, Geneva, Available:, [accessed on 20/12/2011]. http://www.who.int/ipcs/publications/ehc/ehc_224/en/, 2nd ed.
57. Yamaguchi E., Yamanoi A., Ono T., Nagasue N. Experimental investigation of the role of endothelin-1 in idiopathic portal hypertension. J. Gastroenterol. Hepatol. 2007, 22:1134-1140.
58. Yamaji T., Johshita H., Ishibashi M., Takaku F., Ohno H., Suzuki N., Matsumoto H., Fujino M. Endothelin family in human plasma and cerebrospinal fluid. J. Clin. Endocrinol. Metab. 1990, 71:1611-1615.
59. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988, 332:411-415.
60. Yang H.T., Chou H.J., Han B.C., Huang S.Y. Lifelong inorganic arsenic compounds consumption affected blood pressure in rats. Food Chem. Toxicol. 2007, 45:2479-2487.